Evonik and Mectalent have exited the bone implant developer in an acquisition by Globus Medical that follows nearly $12m in funding.
Medical device manufacturer Globus Medical has acquired Synoste, a Norway-based developer of orthopaedic bone lengthening technology, enabling specialty chemical producer Evonik to exit.
Founded in 2012, Synoste has created an orthopaedic implant used to treat patients with leg length deformities. It is made using malleable polymer materials supplied by Evonik and can be modulated through a wireless device to gently stretch out the bone in the patient’s shorter leg.
Globus will now work with Synoste to further develop its technology.…
